487 top medical experts on Gaucher Disease across 46 countries and 29 U.S. states, including 346 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (glucosylceramidase) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the mononuclear phagocyte system. The characteristic Gaucher cells, glycosphingolipid-filled histiocytes, displace normal cells in bone marrow and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Sphingolipidoses (136).
  4. Clinical Trials ClinicalTrials.gov : at least 126 including 7 Active, 65 Completed, 22 Recruiting
  5. Synonyms: Cerebroside Lipidosis Syndrome,  Gaucher Disease Type 1,  Gaucher Disease Type 2,  Glucocerebrosidase Deficiency Disease,  Glucosylceramide Beta-Glucosidase Deficiency Disease,  Neuronopathic Gaucher Disease


  

        

                    


    Computing Expert Listing ...

);